Friday, 21 April 2017

#ResearchSpeak: why is there an increasing number of people with benign MS?

Do you have benign MS? If yes, why? #ResearchSpeak #MSBlog

The restrospective study below suggests the prevalence of benign MS is going up. This is good news and I suspect is due to many factors:

1. Ascertainment bias; diagnosing more people with MS who would not have been diagnosed in the past. This is driven by greater access to neurologists and imaging technology. Another factor is the 'Dr Google' effect. When you search online using a lot of non-specific symptoms MS often comes up on the list of possible causes prompting people to seek a neurological opinion. This is not a bad thing as it should lead to an earlier diagnosis.

2. Change in diagnostic criteria, which allows one to diagnosis MS earlier. This causes the so called Will Rogers phenomenon. "Will" Rogers (November 4, 1879 – August 15, 1935) was an American cowboy, performer, humorist, social commentator and motion picture actor. He was one of the world's best-known celebrities in the 1920s and 1930s. The Will Rogers phenomenon is obtained when moving an element from one set to another set raises the average values of both sets. It is based on the following quote, attributed (perhaps incorrectly) to Will Rogers: "When the Okies left Oklahoma and moved to California, they raised the average intelligence level in both states." The effect will occur when both of these conditions are met: (i) The element being moved is below average for its current set. Removing it will, by definition, raise the average of the remaining elements; (ii) the element being moved is above the current average of the set it is entering. Adding it to the new set will, by definition, raise the average.The paper by Sormani and colleagues has shown this very elegantly in the case of MS (Sormani et al. Will Rogers phenomenon in multiple sclerosis. Ann Neurol. 2008 Oct;64(4):428-33.).

The Will Rogers Phenomenon has occurred as the more active CISers are taken out of the CIS group and added to the MS group. This improves the outcome of both groups because the CISers left behind in the CIS group are more benign and it improves the MS group as the CISers that have been moved from CIS to MS are less active than the old MS group.

As a result of the Will Rogers Phenomenon we cannot use historical controls for MS trials. Each change in the diagnosis of MS alters the prognosis. Therefore in clinical trials we need contemporary placebo of control groups.

3. The effect of DMTs. Could it be that the treatment of MS is increasing the proportion of pwMS who fulfill the current definition of benign MS?

Sartori A, Abdoli M, Freedman MS. Can we predict benign multiple sclerosis? Results of a 20-year long-term follow-up study. J Neurol. 2017 Apr 17. doi: 10.1007/s00415-017-8487-y.

Background: Benign multiple sclerosis (MS) is a discussed clinical entity, with variable reported prevalence (6-64%) requiring at least 5-10 years of clinical observation. Moreover, many benign patients progress with time becoming no longer benign (NLB).

Objectives: The objective of this study is to compare benign MS patients (EDSS ≤3, 10 years from disease onset) who still fulfilled the definition at 20 years to those NLB.

Results: In our retrospective study based on Ottawa Hospital MS Clinic database, 175 benign patients fulfilled the inclusion criteria (clinically definite MS, EDSS ≤3 at 10 years, disease onset from 1983 to 1993, and clinical assessments performed at 10 ± 1 and 20 ± 1 years from onset). Out of the identified patients, 66.3% remained benign at 20 years; however, by changing the definition for benign to EDSS ≤2 or ≤1 at 10 years, they increased to 71.9 and 81.6%, respectively. Female sex, EDSS ≤1 at 10 years, and a pure sensory onset were associated with a benign course, while a pure motor onset with an NLB condition.

Conclusion: According to multivariate analysis, an EDSS ≤2 at 10 years predicted a long-term benign course. Our study questions the current definition of "benign" MS, suggesting a more stringent EDSS cutoff at 10 years to predict long-term benign prognosis.


  1. Will the new blood diagnostics test apparently coming out in the US next month be a game-changer?
    Through this new test could the situation with MS potentially move to something closer to that with a number of cancers - earlier and more effective means of diagnosis allow for better treatment/management???

  2. I think that people are also more likely to go to a doctor these days about symptoms. As a result of higher expectations related to higher standards of living, more information being available to people, more trust in medics generally.

  3. When the 10 years is worked out is this 10 years from the first relapse or 10 years from diagnosis of MS (CIS or MS)? I didn't go to hospital with my first relapse, I only saw the GP.

  4. More people are diagnosed earlier because of the MRI scans, often done for other reasons than looking for MS. That means a lot of people who would present in 20 years time as primary progressives are getting their MS diagnosis now.
    ( In my student days they used to say that a lot of MS-like lesions were first seen at autopsies in people who never had any serious neurological impairment or MS diagnosis.)

  5. A long-retired GP I knew told me that years ago if he suspected possible MS in a patient he simply said nothing to them. No MRI, no treatment, what would have been the point if he could get away with putting it down to 'one of those things'.

    How different the world is today!

    1. Yes as you say no treatment no need to diagnose but that is different today

  6. Yep.... i$ VERY different for B$g Pharma$$$$$$$$$$


Please note that all comments are moderated and any personal or marketing-related submissions will not be shown.